Drug Tariff amendments and reminder about prescription fee exemption checks issued
June 20 2016
NHS Business Services Authority has announced the latest price amendments to Part VIIIA of the June Drug Tariff for England and Wales.
The amended reimbursement prices are as follows:
• bumetanide 1mg tablets - £2.50
• celiprolol 400mg tablets - £39.69
• cimetidine 400mg tablets - £20.24
• dapsone 50mg tablets - £46.19
• desmopressin 10micrograms/dose nasal spray - £24.00
• flecainide 100mg tablets - £10.80
• flecainide 50mg tablets - £10.80
• isosorbide mononitrate 10mg tablets - £3.31
• isosorbide mononitrate 20mg tablets - £4.85
• lamotrigine 5mg dispersible tablets sugar free - £7.45
• lamotrigine 100mg dispersible tablets sugar free - £3.60
• losartan 12.5mg tablets - £8.09
• mefenamic acid 500mg tablets - £9.25
• nitrofurantoin 100mg tablets- £13.99
• nitrofurantoin 50mg tablets - £13.20
• procyclidine 5mg tablets - £12.20
In addition, PSNC has advised pharmacy contractors about the change in the terms of service coming into effect from July 1.
This will require pharmacy contractors to remind anyone claiming exemption from paying NHS prescription charges but who has not provided evidence for claiming the exemption, that NHS checks are routinely undertaken to verify such claims.
Contractors will be expected to advise patients with a statement such as “NHS checks are routinely undertaken to verify that such persons are exempt from payment of NHS prescription charges, as part of arrangements for preventing or detecting fraud or error”. However, PSNC adds: “It is up to pharmacy teams how this is done but it must be in ‘appropriate terms’.”
PSNC has also issued a briefing describing the changes around the NHS fraud checking notification.